In addition to the ability of CAFs to impede the migration of T cells into the TME, suppression of tumor infiltrating cytotoxic activity of CD8+ T cells may be also achieved through the mechanisms that include CAF- derived ligands or ECM components. Here, CD8A is linked to neoplasm.